openPR Logo
Press release

Retinal Biologics Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends

10-01-2024 01:17 PM CET | Health & Medicine

Press release from: Evolve Business Intelligence

Evolve Business Intelligence

Evolve Business Intelligence

The Retinal Biologics market is poised for significant growth, with a market size projected to reach US$ 23.65 billion in 2023 and a compound annual growth rate (CAGR) of 8.41% from 2023 to 2033. This growth is primarily driven by advancements in biological therapies, which offer innovative and effective treatments for retinal diseases. These therapies have shown promising results in managing conditions such as age-related macular degeneration, diabetic retinopathy, and other retinal disorders, contributing to the market's expansion. Despite the promising outlook, the market faces challenges, including limited awareness and diagnosis of retinal diseases. Many patients remain undiagnosed or receive a diagnosis at a late stage, which can impede the timely administration of biological therapies. Additionally, the high cost of these treatments may also act as a barrier to widespread adoption. However, the market is ripe with opportunities, particularly with the advancements in genomic and personalized medicine. These advancements allow for more targeted and individualized treatment approaches, improving patient outcomes and potentially reducing costs over time. The integration of genomic data into the development of biological therapies is expected to enhance the efficacy of treatments and pave the way for new therapeutic options. In summary, the Retinal Biologics market is on a robust growth trajectory driven by advancements in biologic therapies, despite facing challenges related to awareness and diagnosis. The future holds significant promise with the ongoing advancements in genomic and personalized medicine, which are set to revolutionize the treatment landscape for retinal diseases.

For More Information: https://evolvebi.com/report/retinal-biologics-market-analysis/

The report includes 10 key players in the Retinal Biologics market ecosystem that have been strategically profiled, along with the market ranking/share for major players. The key players profiled in the report are:
• Novartis AG
• Hoffmann La Roche Ltd
• ABBVIE INC.
• MeiraGTx Limited
• OncoGene
• Johnson & Johnson
• Allergan
• Bristol-Myers Squibb Company
• Regeneron
• Oxurion NV

The Retinal Biologics market is highly competitive, with major pharmaceutical and biotech companies driving innovation. Leaders like Novartis AG, Hoffmann La Roche Ltd, and ABBVIE INC. dominate the space with advanced therapies. Companies such as MeiraGTx and Oxurion NV are pushing the boundaries with gene and novel biological therapies. Regeneron remains a key player with its well-established products. Overall, the market is set for robust growth as these companies continue to invest in cutting-edge treatments for retinal diseases, addressing unmet medical needs and improving patient outcomes.

For sample report pages - https://evolvebi.com/report/retinal-biologics-market-analysis/

Market Segment By Drug Class with focus on market share, consumption trend, and growth rate of Retinal Biologics Market:
o TNF-α Inhibitor
o VEGF-A Antagonist

Market Segment by Retinal disorder type with focus on market share, consumption trend, and growth rate of Retinal Biologics Market:
o Age-related Macular Degeneration (AMD)
o Diabetic Retinopathy (DR)
o Diabetic Macular Edema (DME)
o Macular Hole
o Uveitis
o Others

Market Segment By distribution channel with a focus on market share, consumption trend, and growth rate of Retinal Biologics Market:
o Hospitals
o Retail Pharmacies
o Specialty Ophthalmology Clinics

Global Retinal Biologics Geographic Coverage:
• North America
o US
o Canada
o Mexico

• Europe
o UK
o Germany
o France
o Italy
o Spain
o Benelux
o Nordic
o Rest of Europe

• Asia Pacific
o China
o Japan
o South Korea
o Indonesia
o Austalia
o Malaysia
o India
o Rest of Asia Pacific

• South America
o Brazil
o Argentina
o Rest of South America

• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of the Middle East & Africa

For any customization, contact us through - https://evolvebi.com/report/retinal-biologics-market-analysis/

Key Matrix for Latest Report Update
• Base Year: 2023
• Estimated Year: 2024
• CAGR: 2024 to 2034

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Biologics Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends here

News-ID: 3674347 • Views:

More Releases from Evolve Business Intelligence

Capsules: Encapsulating Opportunity in the Self-Healing Concrete Market
Capsules: Encapsulating Opportunity in the Self-Healing Concrete Market
The self-healing concrete market is gaining momentum, driven by the need for durable and sustainable infrastructure. Within this innovative field, the capsule segment stands out as a high-opportunity area, offering a promising approach to automatically repair rifts and extend the lifespan of concrete structures. Market Dynamics and Growth Drivers Capsule-based self-healing concrete incorporates micro or macro capsules containing healing agents, such as bacteria, polymers, or mineral precursors, into the concrete mix. When
Flow and Level Sensors: Navigating High Opportunity in the Marine Sensors Market
Flow and Level Sensors: Navigating High Opportunity in the Marine Sensors Market
The marine sensors market is experiencing significant growth, driven by the increasing demand for enhanced vessel safety, operational efficiency, and environmental monitoring. Among the diverse array of marine sensors, the flow and level sensors segment presents a high-opportunity area, playing a vital role in ensuring optimal vessel performance and preventing critical failures. Market Dynamics and Growth Drivers Flow and level sensors provide real-time data on fluid levels and flow rates within various
Seat Mounts: Anchoring Growth in the Dynamic Marine Seats Market
Seat Mounts: Anchoring Growth in the Dynamic Marine Seats Market
The marine seats market is driven by the demand for comfort, safety, and durability in various marine applications, from recreational boating to commercial vessels. Within this dynamic sector, the seat mount segment presents a high-opportunity area, playing a crucial role in ensuring secure and adaptable seating solutions for diverse marine environments. Market Dynamics and Growth Drivers Seat mounts provide the essential connection between marine seats and the vessel's deck, offering stability, adjustability,
PE100 Pipes: The High-Pressure Powerhouse Driving Growth in the HDPE Pipes Market
PE100 Pipes: The High-Pressure Powerhouse Driving Growth in the HDPE Pipes Marke …
The HDPE (High-Density Polyethylene) pipes market is experiencing robust expansion, fueled by its versatility and durability across various applications. Within this thriving sector, the PE100 pipe segment stands out as a high-opportunity area, offering superior performance for high-pressure applications in water, gas, and industrial pipelines. Market Dynamics and Growth Drivers PE100 pipes, characterized by their high density and excellent long-term hydrostatic strength, are designed to withstand demanding operating pressures

All 5 Releases


More Releases for Retinal

Retinal Disorder Treatment: Core Growth Enabler in the Rising Incidence Of Retin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Retinal Disorder Treatment Industry Market Size Be by 2025? In past years, the retinal disorder treatment market has witnessed significant growth. The market worth which stood at $12.59 billion in 2024, is expected to surge to $13.69 billion in 2025, approximating a compound annual growth rate
Retinal Biologics Market Size: Targeted Treatments for AMD, DME & Retinal Diseas …
Retinal Biologics Market reached US$ 24.16 Billion in 2024 and is expected to reach US$ 40.46 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033. Retinal Biologics Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM
Key Influencer in the Retinal Disorder Treatment Market 2025: Rising Incidence O …
What combination of drivers is leading to accelerated growth in the retinal disorder treatment market? The escalation in retinal disorder instances is anticipated to fuel the expansion of the retinal disorder treatment market. Retinal diseases are health issues that influence the retina, the light-sensitive tissue at the rear of the eye, potentially leading to vision loss or significant visual impairment. Treatments for retinal disorders, such as laser therapy, vitrectomy, and retinal
Retinal Biologics Market Report 2024 - Retinal Biologics Market Insights, Size A …
"The Business Research Company recently released a comprehensive report on the Global Retinal Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;